Possible effective single nucleotide polymorphism sites and gene targets of Yiqi Huoxue Jiedu decoction in treatment of advanced ovarian cancer

Zhenhua Zhang,Juan Li,Wenping Lu
DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2018.04.031
2018-01-01
Abstract:Objective To explore the possible effective single nucleotide polymorphism (SNPs) sites and gene targets of Yiqi Huoxue Jiedu decoction in the treatment of advanced ovarian cancer.Methods Three hundred patients with qi-deficiency and blood-stasis type advanced ovarian cancer who visited Guang'anmen Hospital,China Academy of Traditional Chinese Medicine from March 2015 to December 2016 were enrolled.All patients were treated with Yiqi Huoxue Jiedn decoction;peripheral blood was taken 6 months after treatment for gene test.The patients were divided into 2 groups according to the median progression-free survival time;SNPs sites and gene targets sensitive to Chinese herbal treatment were analyzed.Results A total of 242 901 SNPs were screened out,of which 1 773 sites showed significant differences.Differentially expressed genes of messenger RNA were 158 sites,including 58 up-regulated genes and 100 up-regulated genes.Genes involved in the differences of therapeutic efficacy of Chinese herbs were CD40,AFF3,EIF2AK3,WNK1,FYB,FBXL13,PLXNC1,BCL11A,IFI16 and GNG7.Conclusion Effectiveness of traditional Chinese medicine in the treatment of advanced ovarian cancer may be related to SNPs and gene targets.
What problem does this paper attempt to address?